Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AVNS NASDAQ:AVR NYSE:BFLY NYSE:BVS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAvanos Medical$11.43-1.3%$11.61$9.30▼$23.68$531.77M1.15551,334 shs97,607 shsAVRAnteris Technologies Global$4.32-1.8%$4.20$2.34▼$8.79$155.78MN/A205,755 shs4,678 shsBFLYButterfly Network$2.48-3.3%$1.66$1.32▼$4.98$625.57M2.594.12 million shs6.16 million shsBVSBioventus$6.67-1.8%$7.02$5.81▼$14.38$551.47M0.81387,915 shs86,111 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAvanos Medical-2.16%+0.19%-8.93%-6.16%-50.15%AVRAnteris Technologies Global+2.09%+0.92%+5.77%+25.36%+439,999,900.00%BFLYButterfly Network+10.32%+31.20%+64.95%+32.90%+30.87%BVSBioventus-3.28%+2.57%-5.56%-3.96%-42.21%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAvanos Medical$11.43-1.3%$11.61$9.30▼$23.68$531.77M1.15551,334 shs97,607 shsAVRAnteris Technologies Global$4.32-1.8%$4.20$2.34▼$8.79$155.78MN/A205,755 shs4,678 shsBFLYButterfly Network$2.48-3.3%$1.66$1.32▼$4.98$625.57M2.594.12 million shs6.16 million shsBVSBioventus$6.67-1.8%$7.02$5.81▼$14.38$551.47M0.81387,915 shs86,111 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAvanos Medical-2.16%+0.19%-8.93%-6.16%-50.15%AVRAnteris Technologies Global+2.09%+0.92%+5.77%+25.36%+439,999,900.00%BFLYButterfly Network+10.32%+31.20%+64.95%+32.90%+30.87%BVSBioventus-3.28%+2.57%-5.56%-3.96%-42.21%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVNSAvanos Medical 1.50ReduceN/AN/AAVRAnteris Technologies Global 2.60Moderate Buy$16.50281.94% UpsideBFLYButterfly Network 2.40Hold$3.0021.21% UpsideBVSBioventus 2.75Moderate Buy$13.75106.30% UpsideCurrent Analyst Ratings BreakdownLatest AVR, BFLY, BVS, and AVNS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/27/2025AVNSAvanos MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)9/27/2025AVRAnteris Technologies GlobalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025BFLYButterfly NetworkWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)8/12/2025AVNSAvanos MedicalZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold8/4/2025BFLYButterfly NetworkCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingPositive$2.008/1/2025BFLYButterfly NetworkOppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform7/7/2025BVSBioventusCantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$12.00(Data available from 10/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVNSAvanos Medical$692.50M0.77$11.54 per share0.99$18.03 per share0.63AVRAnteris Technologies Global$2.70M57.70N/AN/A$1.74 per share2.48BFLYButterfly Network$82.06M7.59N/AN/A$0.79 per share3.13BVSBioventus$564.14M0.98$0.53 per share12.58$2.80 per share2.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVNSAvanos Medical-$392.10M-$10.07N/A6.61N/A-66.89%6.16%4.57%10/29/2025 (Estimated)AVRAnteris Technologies Global-$76.29MN/A0.00N/AN/AN/AN/AN/A11/10/2025 (Estimated)BFLYButterfly Network-$72.49M-$0.28N/AN/AN/A-71.79%-30.53%-21.80%11/7/2025 (Estimated)BVSBioventus-$156.23MN/AN/A14.49N/A-7.11%15.61%4.01%N/ALatest AVR, BFLY, BVS, and AVNS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/29/2025Q3 2025AVNSAvanos Medical$0.19N/AN/AN/A$164.50 millionN/A8/11/2025Q2 2025 TUAVRAnteris Technologies Global-$0.5333-$0.58-$0.0467-$0.58$0.58 million$0.62 million8/5/2025Q2 2025AVNSAvanos Medical$0.18$0.17-$0.01-$1.66$165.50 million$175.00 million8/1/2025Q2 2025BFLYButterfly Network-$0.07-$0.06+$0.01-$0.06$23.91 million$23.38 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVNSAvanos MedicalN/AN/AN/AN/AN/AAVRAnteris Technologies GlobalN/AN/AN/AN/AN/ABFLYButterfly NetworkN/AN/AN/AN/AN/ABVSBioventusN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVNSAvanos Medical0.122.641.58AVRAnteris Technologies GlobalN/A2.412.38BFLYButterfly NetworkN/A5.684.14BVSBioventus1.851.410.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVNSAvanos Medical95.17%AVRAnteris Technologies GlobalN/ABFLYButterfly Network37.85%BVSBioventus62.94%Insider OwnershipCompanyInsider OwnershipAVNSAvanos Medical2.64%AVRAnteris Technologies Global4.00%BFLYButterfly Network25.18%BVSBioventus33.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVNSAvanos Medical2,22746.40 million45.18 millionOptionableAVRAnteris Technologies Global13836.06 million34.62 millionN/ABFLYButterfly Network460251.74 million188.35 millionOptionableBVSBioventus1,20082.68 million54.46 millionNot OptionableAVR, BFLY, BVS, and AVNS HeadlinesRecent News About These Companies290,700 Shares in Bioventus Inc. $BVS Acquired by Knights of Columbus Asset Advisors LLCOctober 7 at 4:52 AM | marketbeat.comHead to Head Review: Titan Medical (NASDAQ:TMDIF) versus Bioventus (NYSE:BVS)September 30, 2025 | americanbankingnews.comBioventus (NYSE:BVS) Shares Gap Down - Here's What HappenedSeptember 26, 2025 | marketbeat.comBioventus (NYSE:BVS) Stock Price Down 5.3% - Here's What HappenedSeptember 17, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Sells 62,447 Shares of Bioventus Inc. $BVSSeptember 14, 2025 | marketbeat.comCubist Systematic Strategies LLC Grows Holdings in Bioventus Inc. $BVSSeptember 9, 2025 | marketbeat.comBioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare ConferenceSeptember 3, 2025 | globenewswire.comCraig-Hallum Reiterates a Buy Rating on Bioventus (BVS), Sets a $15 PTAugust 13, 2025 | msn.comCanaccord Genuity Sticks to Its Buy Rating for Bioventus (BVS)August 12, 2025 | theglobeandmail.comBioventus to Present at the Canaccord Genuity 45th Annual Global Growth ConferenceAugust 7, 2025 | globenewswire.comBioventus Inc. (BVS) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comBioventus Inc. Reports Q2 2025 Financial ResultsAugust 7, 2025 | tipranks.comBioventus Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 6, 2025 | seekingalpha.comBioventus (BVS) Misses Q2 Earnings and Revenue EstimatesAugust 6, 2025 | zacks.comBioventus Reports Second Quarter Financial ResultsAugust 6, 2025 | globenewswire.comBioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased LiquidityAugust 4, 2025 | globenewswire.comBioventus wins FDA nod for duo of next-gen peripheral nerve stim productsJuly 30, 2025 | massdevice.comBioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation ProductsJuly 30, 2025 | globenewswire.comBioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025July 29, 2025 | globenewswire.comCantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight RatingJuly 16, 2025 | finance.yahoo.comWith 36% stake, Bioventus Inc. (NASDAQ:BVS) seems to have captured institutional investors' interestJuly 10, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAVR, BFLY, BVS, and AVNS Company DescriptionsAvanos Medical NYSE:AVNS$11.43 -0.15 (-1.31%) As of 12:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Anteris Technologies Global NASDAQ:AVR$4.32 -0.08 (-1.82%) As of 12:32 PM EasternAnteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.Butterfly Network NYSE:BFLY$2.48 -0.09 (-3.32%) As of 12:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.Bioventus NYSE:BVS$6.66 -0.13 (-1.84%) As of 12:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Marvell Insiders Buy Shares—Should Investors Follow Suit? TrumpRx Brings Pfizer Into the Green—Is It a Buy? Behind D-Wave's Massive Week (And Why Rivals Also Popped) Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal 2 Defense Stocks Riding 2025’s Massive Momentum Wave Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback Alphabet: After Its Best Quarter in Decades, Is It Time to Buy? Best Stocks Under $15? 3 Low-Priced Picks With Upside Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
